Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3065 |
|
Actual shortage: | 232 (8%) | |
Anticipated shortage: | 15 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2809 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
30 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-DONEPEZIL | 10MG | TABLET | Resolved | 2022-03-04 | 2022-03-09 | 156033 |
APO-PERINDOPRIL | 4MG | TABLET | Resolved | 2022-03-04 | 2022-03-24 | 156036 |
APO-QUINAPRIL/HCTZ | 12.5MG 20MG | TABLET | Actual shortage | 2022-03-04 | 2022-05-09 | 156039 |
APO-ONDANSETRON | 4MG | SOLUTION | Resolved | 2022-03-07 | 2022-07-15 | 156214 |
APO-SALBUTAMOL HFA | 100MCG | METERED-DOSE AEROSOL | Resolved | 2022-03-09 | 2022-06-17 | 156387 |
APO-CANDESARTAN | 32MG | TABLET | Actual shortage | 2022-03-11 | 2022-03-11 | 156534 |
APO-COLESEVELAM | 625MG | TABLET | Resolved | 2022-03-11 | 2022-04-01 | 156537 |
APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2022-03-11 | 2022-05-05 | 156540 |
APO-QUETIAPINE XR | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-03-11 | 2022-04-06 | 156543 |
APO-QUETIAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-03-11 | 2022-04-06 | 156546 |
APO-QUETIAPINE XR | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-03-11 | 2022-04-06 | 156549 |
APO-SIMVASTATIN | 40MG | TABLET | Resolved | 2022-03-11 | 2022-03-25 | 156552 |
APO-TADALAFIL | 2.5MG | TABLET | Resolved | 2022-03-11 | 2022-04-01 | 156555 |
APO-TRAMADOL | 50MG | TABLET | Resolved | 2022-03-15 | 2022-05-20 | 156758 |
APO-TRAMADOL/ACET | 37.5MG 325MG | TABLET | Resolved | 2022-03-15 | 2022-05-19 | 156762 |
APO-TELMISARTAN-AMLODIPINE | 10MG 80MG | TABLET | Actual shortage | 2022-03-16 | 2022-09-14 | 156794 |
ANAFRANIL | 25MG | TABLET | Resolved | 2022-03-18 | 2022-04-04 | 156980 |
APO-AMLODIPINE-ATORVASTATIN | 80MG 10MG | TABLET | Resolved | 2022-03-18 | 2022-04-01 | 156983 |
APO-DESVENLAFAXINE | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-03-18 | 2022-04-06 | 156987 |
APO-DIVALPROEX | 500MG | TABLET (DELAYED-RELEASE) TABLET (ENTERIC-COATED) | Resolved | 2022-03-18 | 2022-09-30 | 156990 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71029 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71032 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71035 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71038 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71051 | ||
APO-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71054 |
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71057 | ||
APO-ZOLMITRIPTAN | 2.5MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71072 |
COATED DAILY LOW DOSE ASA 81 MG | 81MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-01-03 | 2019-01-04 | 71083 |
BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-01-03 | 2019-01-03 | 71090 |
IBUPROFEN LIQUID GEL CAPSULES | 200MG | CAPSULE | Discontinued | 2019-01-03 | 2019-01-03 | 71095 |
APO-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71101 |
IBUPROFEN CAPLETS | 200MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71112 |
APO-NITROGLYCERIN | 0.4MG | METERED-DOSE PUMP | Discontinued | 2019-01-04 | 2019-01-04 | 71189 |
ACETAMINOPHEN HEADACHE ULTRA RELIEF | 500MG 65MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71192 |
APO-CEFPROZIL | 250MG | TABLET | Discontinued | 2019-01-04 | 2019-02-21 | 71195 |
ACID CONTROL | Discontinued | 2019-01-04 | 2019-01-04 | 71198 | ||
APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71201 |